Parmar MT. Low Beta Is Not Low Risk: Evidence and Investor Implications from Five Indian Pharmaceutical Stocks, 2021–2025. int. j. eng. mgmt. res. [Internet]. 2026 Jun. 12 [cited 2026 Sep. 28];16(3):113-25. Available from: https://ijemr.vandanapublications.com/index.php/j/article/view/1941